SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · IEX Real-Time Price · USD
37.27
-1.26 (-3.27%)
At close: Jul 2, 2024, 4:00 PM
37.49
+0.22 (0.59%)
After-hours: Jul 2, 2024, 4:28 PM EDT
SpringWorks Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SWTX stock have an average target of 66.6, with a low estimate of 52 and a high estimate of 74. The average target predicts an increase of 78.70% from the current stock price of 37.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SWTX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +98.55% | Jun 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +98.55% | May 31, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +98.55% | May 6, 2024 |
JP Morgan | JP Morgan | Buy Maintains $73 → $74 | Buy | Maintains | $73 → $74 | +98.55% | Mar 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $73 → $74 | Strong Buy | Maintains | $73 → $74 | +98.55% | Mar 6, 2024 |
Financial Forecast
Revenue This Year
139.41M
from 5.45M
Increased by 2,459.39%
Revenue Next Year
324.77M
from 139.41M
Increased by 132.96%
EPS This Year
-4.71
from -5.15
EPS Next Year
-3.54
from -4.71
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 173.7M | 420.0M | 759.0M | 1.2B | 2.1B |
Avg | 139.4M | 324.8M | 530.6M | 1.2B | 2.1B |
Low | 88.2M | 209.3M | 296.0M | 1.2B | 2.0B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 3,088.5% | 201.3% | 133.7% | 132.6% | 76.1% |
Avg | 2,459.4% | 133.0% | 63.4% | 126.0% | 71.1% |
Low | 1,519.2% | 50.2% | -8.9% | 117.1% | 64.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -4.05 | -1.97 | 0.29 |
Avg | -4.71 | -3.54 | -1.94 |
Low | -6.20 | -4.83 | -2.99 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.